ROVI

Welcome to the Brand page for “ROVI”, which is offered here for In the statement, class 10, has been updated in accordance with the f-note dated 4/20/2020.;pharmaceutical products, anticoagulants, antihistamines, suppositories, anti-inflammatories, vaccines, anti-psychotics, antivirals, antithrombotics, antiseptics used for the treatment of the skin, glaucoma, thrombosis, allergies, infections, pain and inflammation; sanitary products for medical use; dietetic substances, foods for medical use, food for babies; plasters for medical use, material for dressings, medical dressings, bandages, gauze, polymer matrix bandages and gauze; material for stopping teeth and for dental impressions; disinfectants for sanitary use; preparations for destroying vermin; fungicides, herbicides;[ surgical, ] medical, [ dental and veterinary ] apparatus and instruments, catheters, medical syringes, [ apparatus for artificial respiration, drug delivery systems, ] injection devices for pharmaceuticals [, artificial limbs, eyes and teeth; suture materials ] * ; excluding surgical instruments and apparatus other than syringes, injectors, vials and catheters for medical use *;scientific and technological services, research in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; industrial analysis and research services in the field of oral carbohydrates, peptides, enhancers for oral carbohydrates and peptides, diabetic foot ulcers, chronic ulcers, cancer, neurodegenerative pain, thrombosis, diabetes, alzheimer's disease, schizophrenia and in the field of vaccines and medicines; computer hardware and software design and development;.

Its status is currently believed to be active. Its class is unavailable. “ROVI” is believed to be currently owned by “Laboratorios Farmacéuticos Rovi, S.A.”


Owner:
LABORATORIOS FARMACÉUTICOS ROVI, S.A.
Owner Details
Description:
In the statement, Class 10, has been updated in accordance with the F-note dated 4/20/2020.;Pharmaceutical products, anticoagulants, antihistamines, suppositories, anti-inflammatories, vaccines, anti-psychotics, antivirals, antithrombotics, antiseptics used for the treatment of the skin, glaucoma, thrombosis, allergies, infections, pain and inflammation; sanitary products for medical use; dietetic substances, foods for medical use, food for babies; plasters for medical use, material for dressings, medical dressings, bandages, gauze, polymer matrix bandages and gauze; material for stopping teeth and for dental impressions; disinfectants for sanitary use; preparations for destroying vermin; fungicides, herbicides;[ Surgical, ] medical, [ dental and veterinary ] apparatus and instruments, catheters, medical syringes, [ apparatus for artificial respiration, drug delivery systems, ] injection devices for pharmaceuticals [, artificial limbs, eyes and teeth; suture materials ] * ; excluding surgical instruments and apparatus other than syringes, injectors, vials and catheters for medical use *;Scientific and technological services, research in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; industrial analysis and research services in the field of oral carbohydrates, peptides, enhancers for oral carbohydrates and peptides, diabetic foot ulcers, chronic ulcers, cancer, neurodegenerative pain, thrombosis, diabetes, Alzheimer's disease, schizophrenia and in the field of vaccines and medicines; computer hardware and software design and development;
Categories: STATEMENT